We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Calidi Biotherapeutics Logo

Calidi Biotherapeutics

Calidi Biotherapeutics are committed to being at the forefront of cutting-edge research and innovation in the realm of oncology and arming the immune system to kill cancer. Their solutions are are grounded in their cutting-edge platform that harnesses allogeneic stem cell technologies combined with viruses engineered to attack cancer, namely the vaccinia virus and adenovirus.

Latest Calidi Biotherapeutics Content

Shielding Oncolytic Viruses From the Immune System To Improve Cancer Treatment content piece image
Industry Insight

Shielding Oncolytic Viruses From the Immune System To Improve Cancer Treatment

While oncolytic virus (OV) therapy has garnered increasing attention from the cancer research community, this therapeutic strategy doesn’t come without its challenges, as a patient’s immune system can sometimes mount a response to the OVs before they reach their intended target. To address this, Calidi Biotherapeutics has developed cell-based platforms to shield OVs from the immune system, so that they can effectively target and destroy the cancer cells.
Advertisement
Advertisement
Advertisement
Decoratvive background images
Never miss a story
with the Breaking Science News daily newsletter